This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique. Active years: 2011-2013.
Location History:
- ointe a Pitre Cedex, FR (2011)
- Abynes Cedex, FR (2013)
- Abymes, FR (2013)
Company Filing History:
3 out of 897 
2 out of 5,383 
Years Active: 2011-2013
Title: Ronald Perraut: Innovator in Nucleic Acid Constructs
Introduction
Ronald Perraut is a notable inventor based in Abynes Cedex, France. He has made significant contributions to the field of biotechnology, particularly in the development of constructs involving nucleic acids. With a total of 3 patents to his name, his work has implications for various applications in genetic engineering and protein expression.
Latest Patents
Among his latest patents, Ronald Perraut has developed constructs that modify nucleic acids encoding MSP4 and MSP5. These constructs lead to the expression of recombinant MSP4 and MSP5 polypeptides as soluble, secreted proteins in a baculovirus-insect cell expression system. Notably, it was discovered that these recombinant polypeptides contain an EGF-like domain at the C-terminus, which is properly folded within the polypeptide.
Career Highlights
Throughout his career, Ronald has worked with prestigious institutions such as Institut Pasteur and the Centre Nationale De La Recherche Scientifique. His research has contributed to advancements in the understanding of protein structures and their functionalities.
Collaborations
Ronald has collaborated with notable coworkers, including Shirley Longacre and Hannah Polson. These partnerships have likely enriched his research and innovation efforts.
Conclusion
In summary, Ronald Perraut is a distinguished inventor whose work in nucleic acid constructs has paved the way for advancements in biotechnology. His contributions continue to influence the field and inspire future innovations.